MAPS publishes a Psychedelic Science in Public Interest literature review on psychedelic research, ethics, policy, and public benefit

MAPS announces publication of a Psychedelic Science in Public Interest literature review focused on how psychedelic research can serve the public good. The review centers ethics, policy, and social impact alongside scientific evidence, with attention to how access, regulation, and public interest frameworks shape the field. Psychedelic science sits at the intersection of clinical promise, commercialization, and drug policy change. A public interest literature review in this context likely synthesizes research findings with concerns about equity, governance, and who benefits from emerging therapeutic and legal models. MAPS places the review within broader efforts to guide psychedelic development beyond narrow medical or market outcomes. Public benefit, responsible stewardship, and transparent evaluation of risks and societal consequences are treated as core considerations for the future of psychedelic research.